Seeking Alpha

Genetic Technologies (GENE +0.8%) announces that ImmunAid Limited, in which the company holds a...

Genetic Technologies (GENE +0.8%) announces that ImmunAid Limited, in which the company holds a 45% direct equity interest and is currently the largest shareholder, has just been granted its first patent by the USPTO. The company has been working since 2001 to develop an entirely new treatment strategy for patients with life-threatening diseases, whereby the unique immune cycle of each individual patient is monitored on an individual basis, in order to determine the precise optimal time to deliver treatment. The company received its first round of funding in 2011.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)